A primer of collagen disease.
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis; D002493:Central Nervous System Diseases / Q000209:etiology; D002648:Child; D003095:Collagen Diseases / Q000175:diagnosis; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D003882:Dermatomyositis / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000209:etiology; D005938:Glucocorticoids; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications; D011342:Procainamide / Q000009:adverse effects; D011379:Prognosis; D012594:Scleroderma, Localized / Q000175:diagnosis; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D012867:Skin / Q000473:pathology; D012877:Skin Manifestations; D013256:Steroids / Q000627:therapeutic use; D013472:Sunlight; D014777:Virus Diseases / Q000150:complications
D000893:Anti-Inflammatory Agents; D000906:Antibodies; D003280:Contraceptives, Oral, Synthetic; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013256:Steroids; D011342:Procainamide